Human immunodeficiency virus in correctional facilities: A review

被引:127
作者
Spaulding, A
Stephenson, B
Macalino, G
Ruby, W
Clarke, JG
Flanigan, TP
机构
[1] CDCP, Correct & Substance Abuse Unit, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA
[2] Brown Univ, Div Infect Dis, Providence, RI 02912 USA
关键词
D O I
10.1086/341418
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is estimated that up to one-fourth of the people living with human immunodeficiency virus (HIV) infection in the United States pass through a correctional facility each year. The majority of persons who enter a correctional facility today will return home in the near future. Most inmates with HIV infection acquire it in the outside community; prison does not seem to be an amplifying reservoir. How correctional health services deal with the HIV-infected person has important implications to the overall care of HIV-infected people in the community. Routine HIV testing is well accepted. Combination antiretroviral therapy has been associated with a reduction in mortality in prisons. A link between area HIV specialists and correctional health care providers is an important partnership for ensuring that HIV-infected patients have optimal care both inside prison and after release.
引用
收藏
页码:305 / 312
页数:8
相关论文
共 53 条
[1]  
ADIMORA AA, 2000, 7 C RETR OPP INF PRO
[2]   Predictors of HIV infection among newly sentenced male prisoners [J].
Altice, FL ;
Mostashari, F ;
Selwyn, PA ;
Checko, PJ ;
Singh, R ;
Tanguay, S ;
Blanchette, EA .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 (05) :444-453
[3]  
[Anonymous], 2001, MMWR Recomm Rep, V50, P1
[4]  
[Anonymous], 1999, MMWR, V48, DOI [DOI 10.1037/E547822006-001, 10.1037/e547822006-001]
[5]  
Beck Allen, 2001, Bureau of justice statistics bulletin: Prisoners in 2000
[6]   Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates [J].
Bock, NN ;
Rogers, T ;
Tapia, JR ;
Herron, GD ;
DeVoe, B ;
Geiter, LJ .
CHEST, 2001, 119 (03) :833-837
[7]   Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. [J].
Bozzette, SA ;
Joyce, G ;
McCaffrey, DF ;
Leibowitz, AA ;
Morton, SC ;
Berry, SH ;
Rastegar, A ;
Timberlake, D ;
Shapiro, MF ;
Goldman, DP .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :817-823
[8]   TRANSMISSION OF HIV-1 WITHIN A STATEWIDE PRISON SYSTEM [J].
BREWER, TF ;
VLAHOV, D ;
TAYLOR, E ;
HALL, D ;
MUNOZ, A ;
POLK, BF .
AIDS, 1988, 2 (05) :363-367
[9]  
*BUR JU ST STAT, 1993, NJC136949 BUR JUST S
[10]  
*BUR JUST STAT, 2002, 174463 NJC BUR JUST